Immage Biotherapeutics Corp. (IMMG)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 22, 2026
Immage Biotherapeutics Market Cap
Immage Biotherapeutics has a market cap or net worth of $152 as of October 27, 2026. It is the 52,848th most valuable company in the world and the 8,807th biggest in the United States.
Market Cap
152.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,807 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since September 14, 2015, Immage Biotherapeutics's market cap has decreased from 18.04M to 152.00, a decrease of -100.00%. That is a compound annual growth rate of -65.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 152.00 | - |
| Dec 2, 2022 | 152.00 | -99.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobac Pharmaceuticals | 250.00 |
| NanoLogix | 163.00 |
| Kiromic BioPharma | 157.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |